Suppr超能文献

一种新的血管活性肠肽生物测定法:导致水样腹泻综合征。

A new bioassay of VIP: results in watery diarrhoea syndrome.

作者信息

Laburthe M C, Dupont C M, Besson J D, Rousset M, Rosselin G E

出版信息

Gut. 1980 Jul;21(7):619-23. doi: 10.1136/gut.21.7.619.

Abstract

Cyclic AMP accumulation in human colon adenocarcinoma cells in culture (HT-29) is known to be particularly sensitive to the stimulating action of vasoactive intestinal peptide (VIP). This property was exploited as a means of investigating the possible role of VIP as a humoral mediator in the watery diarrhoea syndrome. Our results showed that plasma from two patients with watery diarrhoea syndrome associated with ganglioneuroblastoma and pheochromocytoma strongly stimulated cyclic AMP accumulation in HT-29 cells, whereas plasma from normal subjects and patients with other diarrhoeal disorders had no effect. The stimulation induced by serial dilutions of plasma from patients paralleled the VIP-induced response. Preincubation of these plasmas with specific anti-VIP antibody prevented their stimulatory effects. Plasma sampled after the arrest of diarrhoea (spontaneous or after surgical resection of tumours) elicited AMP rise in HT-29 cells. Tumour extract stimulated cyclic AMP accumulation in HT-29 cells with a dose-response curve which was superimposable on the one obtained with standard VIP. The results lend support to the hypothesis that VIP is a humoral mediator in WDS and suggest that the diarrhoea is mediated through a VIP-induced accumulation of cyclic AMP in intestinal epithelial cells.

摘要

已知培养的人结肠腺癌细胞(HT - 29)中环状AMP的积累对血管活性肠肽(VIP)的刺激作用特别敏感。利用这一特性来研究VIP作为体液介质在水样腹泻综合征中可能发挥的作用。我们的结果表明,两名患有与神经节神经母细胞瘤和嗜铬细胞瘤相关的水样腹泻综合征患者的血浆强烈刺激HT - 29细胞中环状AMP的积累,而正常受试者和患有其他腹泻疾病患者的血浆则无此作用。患者血浆系列稀释后的刺激作用与VIP诱导的反应相似。这些血浆与特异性抗VIP抗体预孵育可阻止其刺激作用。腹泻停止后(自发停止或肿瘤手术切除后)采集的血浆可引起HT - 29细胞中AMP升高。肿瘤提取物刺激HT - 29细胞中环状AMP的积累,其剂量反应曲线与用标准VIP获得的曲线重叠。这些结果支持了VIP是水样腹泻综合征中体液介质的假说,并表明腹泻是通过VIP诱导肠上皮细胞中环状AMP积累介导的。

相似文献

1
一种新的血管活性肠肽生物测定法:导致水样腹泻综合征。
Gut. 1980 Jul;21(7):619-23. doi: 10.1136/gut.21.7.619.
2
分泌血管活性肠肽的胰腺和神经节神经母细胞瘤(血管活性肠肽瘤)的临床病理研究
Br Med J (Clin Res Ed). 1981 May 30;282(6278):1767-71. doi: 10.1136/bmj.282.6278.1767.
3
血管活性肠肽瘤与水样腹泻综合征
S Afr Med J. 1978 Jul 8;54(2):53-6.
5
血管活性肠肽(VIP)作为水样腹泻综合征的介质。
World J Surg. 1979 Sep 20;3(5):559-63. doi: 10.1007/BF01654760.
7
成人神经节神经瘤-嗜铬细胞瘤伴发的水样腹泻综合征:血管活性肠肽、降钙素和儿茶酚胺的鉴定及其生物活性评估
Cancer. 1977 Oct;40(4):1526-32. doi: 10.1002/1097-0142(197710)40:4<1526::aid-cncr2820400425>3.0.co;2-7.
8
血管活性肠肽测量在鉴别韦纳-莫里森综合征和假性韦纳-莫里森综合征中的应用
Clin Endocrinol (Oxf). 1976;5 Suppl:223S-228S. doi: 10.1111/j.1365-2265.1976.tb03831.x.
9
伴有分泌血管活性肠肽的神经节神经母细胞瘤的水样腹泻
Arch Dis Child. 1980 Dec;55(12):929-36. doi: 10.1136/adc.55.12.929.
10
胰腺、肾上腺髓质、甲状腺及肺部肿瘤分泌血管活性肠肽的证据:对统一的APUD概念的支持。
Clin Endocrinol (Oxf). 1976;5 Suppl:201S-204S. doi: 10.1111/j.1365-2265.1976.tb03828.x.

本文引用的文献

1
胰岛细胞瘤与难治性水样腹泻及低钾血症综合征
Am J Med. 1958 Sep;25(3):374-80. doi: 10.1016/0002-9343(58)90075-5.
3
肠分泌:肽类的刺激作用。
Science. 1971 Oct 22;174(4007):422-4. doi: 10.1126/science.174.4007.422.
4
血管活性肠肽在哺乳动物和鸟类胃肠道中的细胞定位。
Gut. 1974 Sep;15(9):720-4. doi: 10.1136/gut.15.9.720.
5
关于促胰液素在胰岛细胞瘤致腹泻综合征中潜在作用的研究。
Ann Surg. 1972 Sep;176(3):394-402. doi: 10.1097/00000658-197209000-00015.
6
肠分泌
Gastroenterology. 1974 May;66(5):1063-84.
7
血管活性肠肽与水样腹泻综合征
Lancet. 1973 Jul 7;2(7819):14-6. doi: 10.1016/s0140-6736(73)91947-8.
8
成为VIP还是不成为VIP。
Gastroenterology. 1979 Feb;76(2):417-20.
9
大鼠肠上皮细胞膜中对血管活性肠肽敏感的腺苷酸环化酶的特性研究
Biochim Biophys Acta. 1978 Dec 18;544(3):474-81. doi: 10.1016/0304-4165(78)90321-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验